John M. Aoki

Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation.

Denovo Ventures LLC provides enterprise hosting, cloud computing and professional services. The firm also provides cloud services which include public cloud, hybrid cloud, disaster recovery and JDE as a services, managed services include technical, development, applications and SAP technical managed services. The company was founded by Mark Goedde in 2003 and is headquartered in Niwot, CO.

Dean Foods Co. engages in the manufacture, sale, and direct-to-store distribution of fluid milk and other dairy products. Its portfolio includes the DairyPure and TruMoo brands, along with other regional dairy brands such as Alta Dena, Berkeley Farms, Country Fresh, Dean's, Friendly's, Garelick Farms, LAND O LAKES milk and cultured products, Lehigh Valley Dairy Farms, Mayfield, McArthur, Meadow Gold, Oak Farms, PET, T.G. Lee, and Tuscan. The company was founded by Samuel E. Dean, Sr. in 1925 and is headquartered in Dallas, TX.